Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AHGNYSE:INUVNASDAQ:LTBRNASDAQ:OABI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAHGAkso Health Group$1.43+4.7%$1.21$0.60▼$2.35$198.26M-0.1971,908 shs4,456 shsINUVInuvo$0.40+1.3%$0.38$0.19▼$0.79$56.74M0.98799,064 shs397,701 shsLTBRLightbridge$9.19-0.8%$8.44$2.21▼$16.90$191.93M1.741.28 million shs438,722 shsOABIOmniAb$1.68-4.0%$2.40$1.63▼$4.96$213.74M0.1611,070 shs814,055 shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAHGAkso Health Group+3.64%+4.01%+47.06%+15.85%+82.69%INUVInuvo+1.28%+1.67%+24.28%-15.14%+21.94%LTBRLightbridge-0.76%+0.33%+34.75%-4.07%+258.98%OABIOmniAb-4.00%-6.67%-19.62%-49.24%-64.03%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAHGAkso Health Group0.5695 of 5 stars0.05.00.00.01.90.00.0INUVInuvo1.5069 of 5 stars3.80.00.00.01.20.00.6LTBRLightbridge0.2202 of 5 stars0.02.00.00.01.90.80.0OABIOmniAb2.0656 of 5 stars3.51.00.00.00.03.31.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAHGAkso Health Group 0.00N/AN/AN/AINUVInuvo 3.50Strong Buy$2.00406.20% UpsideLTBRLightbridge 0.00N/AN/AN/AOABIOmniAb 3.00Buy$7.00316.67% UpsideCurrent Analyst Ratings BreakdownLatest INUV, OABI, AHG, and LTBR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/27/2025OABIOmniAbRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$7.00 ➝ $4.003/20/2025OABIOmniAbBenchmarkSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$8.00 ➝ $6.003/19/2025OABIOmniAbHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$11.00 ➝ $11.003/11/2025INUVInuvoHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$2.00(Data available from 5/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAHGAkso Health Group$8.45M24.56N/AN/A$0.95 per share1.50INUVInuvo$83.79M0.68N/AN/A$0.12 per share3.29LTBRLightbridgeN/AN/AN/AN/A$2.23 per shareN/AOABIOmniAb$26.39M7.77N/AN/A$2.69 per share0.62Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAHGAkso Health Group-$9.46MN/A0.00∞N/AN/AN/AN/AN/AINUVInuvo-$10.39M-$0.04N/A19.76N/A-10.59%-57.24%-27.77%N/ALTBRLightbridge-$7.91M-$0.81N/A∞N/AN/A-37.03%-35.89%5/12/2025 (Estimated)OABIOmniAb-$50.62M-$0.60N/AN/AN/A-308.78%-20.97%-18.05%5/8/2025 (Estimated)Latest INUV, OABI, AHG, and LTBR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025OABIOmniAb-$0.17N/AN/AN/A$4.49 millionN/A3/18/2025Q4 2024OABIOmniAb-$0.13-$0.12+$0.01-$0.12$10.13 million$10.80 million2/26/2025Q4 2024LTBRLightbridgeN/A-$0.24N/A-$0.24N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAHGAkso Health GroupN/AN/AN/AN/AN/AINUVInuvoN/AN/AN/AN/AN/ALTBRLightbridgeN/AN/AN/AN/AN/AOABIOmniAbN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAHGAkso Health GroupN/AN/AN/AINUVInuvoN/A0.780.78LTBRLightbridgeN/A23.3123.31OABIOmniAbN/A4.624.62Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAHGAkso Health Group1.21%INUVInuvo29.36%LTBRLightbridge9.14%OABIOmniAb72.08%Insider OwnershipCompanyInsider OwnershipAHGAkso Health GroupN/AINUVInuvo5.00%LTBRLightbridge6.50%OABIOmniAb8.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAHGAkso Health Group40145.72 millionN/ANot OptionableINUVInuvo80143.61 million128.56 millionNot OptionableLTBRLightbridge620.89 million14.74 millionOptionableOABIOmniAb7122.14 million129.07 millionOptionableINUV, OABI, AHG, and LTBR HeadlinesRecent News About These CompaniesVERAXA Biotech AG and OmniAb, Inc. Announce Co-Discovery Alliance for Novel Bispecific Antibody Drug Conjugate Program Targeting Solid TumorsMay 5 at 1:16 PM | quiverquant.comVERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate ProgramMay 5 at 1:00 AM | globenewswire.comOmniAb (OABI) Expected to Announce Earnings on ThursdayMay 3 at 4:45 AM | marketbeat.comCompanies Like OmniAb (NASDAQ:OABI) Are In A Position To Invest In GrowthApril 25, 2025 | finance.yahoo.comOmniAb, Inc. (NASDAQ:OABI) Short Interest Up 21.3% in MarchApril 22, 2025 | marketbeat.comOmniAb, Inc. (NASDAQ:OABI) Shares Purchased by JPMorgan Chase & Co.April 22, 2025 | marketbeat.comOmniAb Announces Two New Appointments to its Board of DirectorsApril 21, 2025 | finance.yahoo.comOmniAb Appoints New Directors to BoardApril 21, 2025 | tipranks.comQ1 Earnings Estimate for OmniAb Issued By Leerink PartnrsApril 20, 2025 | marketbeat.comLeerink Partners Sticks to Their Buy Rating for OmniAb (OABI)April 20, 2025 | markets.businessinsider.comInsider Selling: OmniAb, Inc. (NASDAQ:OABI) Insider Sells 7,206 Shares of StockApril 9, 2025 | marketbeat.comInsider Selling: OmniAb, Inc. (NASDAQ:OABI) CEO Sells $38,764.00 in StockApril 9, 2025 | marketbeat.comADAR1 Capital Management LLC Has $985,000 Stock Position in OmniAb, Inc. (NASDAQ:OABI)April 9, 2025 | marketbeat.comOmniAb, Inc. (NASDAQ:OABI) CEO Matthew W. Foehr Sells 19,382 SharesApril 9, 2025 | marketbeat.comKurt A. Gustafson Sells 11,963 Shares of OmniAb, Inc. (NASDAQ:OABI) StockApril 2, 2025 | insidertrades.comAnalyst Forecasts Just Became More Bearish On OmniAb, Inc. (NASDAQ:OABI)March 29, 2025 | uk.finance.yahoo.comOmniAb price target lowered to $4 from $7 at RBC CapitalMarch 27, 2025 | markets.businessinsider.comOmniAb price target lowered to $4 from $8 at TD CowenMarch 21, 2025 | msn.comOmniAb price target lowered to $6 from $8 at BenchmarkMarch 21, 2025 | markets.businessinsider.comOmniAb, Inc. (NASDAQ:OABI) Director John L. Higgins Acquires 125,750 SharesMarch 21, 2025 | insidertrades.comOmniAb Stock Short Interest Report | NASDAQ:OABI | BenzingaMarch 19, 2025 | benzinga.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeINUV, OABI, AHG, and LTBR Company DescriptionsAkso Health Group NASDAQ:AHG$1.42 +0.06 (+4.74%) Closing price 05/5/2025 03:50 PM EasternExtended Trading$1.39 -0.04 (-2.46%) As of 05/5/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. It also offers consultancy and information technology support services; provides health treatment services; sells medical devices; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.Inuvo NYSE:INUV$0.40 +0.01 (+1.28%) Closing price 05/5/2025 04:00 PM EasternExtended Trading$0.44 +0.04 (+11.11%) As of 04:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Inuvo, Inc. engages in the advertising technology and services business primarily in the United States. It sells information technology solutions to brands, agencies, and large consolidators of advertising demand (platforms). Its platforms optimize the purchase and placement of advertising in real time. The company's products and services include IntentKey, an artificial intelligence-based consumer intent recognition system designed to reach targeted mobile and desktop in-market audiences which can serve multiple creative formats including display, video, audio and native across multiple device types including desktop, mobile, tablet, connected/smart TV and game consoles. It also offers Bonfire, a marketing and advertising solution which can be provided directly to brands and where a collection of data, analytics, software and publishing is used to align advertising messages with consumers across websites online. The company's marketing channels consist of websites, social media, blogs, public relations, trade shows, and conferences. Inuvo, Inc. is headquartered in Little Rock, Arkansas.Lightbridge NASDAQ:LTBR$9.19 -0.07 (-0.76%) Closing price 05/5/2025 04:00 PM EasternExtended Trading$9.12 -0.06 (-0.71%) As of 04:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lightbridge Corporation, together with its subsidiaries, engages in developing nuclear fuel technology. It develops and commercializes metallic nuclear fuels. The company was formerly known as Thorium Power, Ltd. and changed its name to Lightbridge Corporation in September 2009. Lightbridge Corporation is headquartered in Reston, Virginia.OmniAb NASDAQ:OABI$1.68 -0.07 (-4.00%) Closing price 05/5/2025 04:00 PM EasternExtended Trading$1.70 +0.02 (+0.89%) As of 05/5/2025 07:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.OmniAb, Inc., a biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States. The company's technology platform creates and screens diverse antibody repertoires and identify optimal antibodies for partners' drug development efforts. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company's OmniFlic, a bispecific rat, and OmniClic, a bispecific chicken, designed for discovery of bispecific antibody applications; OmniTaur, which provides unique structural characteristics of cow antibodies for complex targets; and OmniDeep, a suite of in silico, an AI and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Monster Beverage Stock: Short Report Risks vs Upside Potential Onsemi Stock Confirms Bottom, But What’s the Upside? 3 Reasons Tesla Should Be a $300 Stock by June Amazon: Why The Great Comeback Rally Could Be About to Begin Is Reddit Stock a Buy, Sell, or Hold After Earnings Release? MarketBeat Week in Review – 04/28 - 05/02 ExxonMobil: Production Offset Prices, Capital Return Safe in 2025 Warning or Opportunity After Super Micro Computer's Earnings Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
